← Back to Search

Other

DISC-0974 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Disc Medicine, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial tests a new drug called DISC-0974 in healthy adults to see if it is safe and how the body processes it. Researchers will monitor how the drug moves through the body and its effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Group I: Healthy Volunteer: Single Ascending Dose of PlaceboExperimental Treatment1 Intervention
Single Intravenous (IV) or Subcutaneous (SC) ascending dose in healthy volunteers
Group II: Healthy Volunteer: Single Ascending Dose of DISC-0974Experimental Treatment1 Intervention
Single Intravenous (IV) or Subcutaneous (SC) ascending dose in healthy volunteers
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DISC-0974
2021
Completed Phase 1
~50
Placebo
1995
Completed Phase 3
~2670

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Disc Medicine, IncLead Sponsor
5 Previous Clinical Trials
445 Total Patients Enrolled
William Savage, MD, PhDStudy DirectorDisc Medicine
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top